help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-1939
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/5/2631    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ostberg, J. E.
Right arrow Articles by Conway, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ostberg, J. E.
Right arrow Articles by Conway, G. S.
Related Collections
Right arrow Female Endocrinology
Right arrow Metabolism
Right arrow Obesity
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 5 2631-2635
Copyright © 2005 by The Endocrine Society

Excess Visceral and Hepatic Adipose Tissue in Turner Syndrome Determined by Magnetic Resonance Imaging: Estrogen Deficiency Associated with Hepatic Adipose Content

Julia E. Ostberg, E. Louise Thomas, Gavin Hamilton, M. Javad Hosseinzadeh Attar, Jimmy D. Bell and Gerard S. Conway

Department of Endocrinology, University College London Hospitals (J.E.O., M.J.H.A., G.S.C.), London W1T 3AA, United Kingdom; and Robert Steiner Magnetic Resonance Unit, Imaging Sciences Department, Medical Research Council Clinical Sciences Center, Hammersmith Hospital, Imperial College (E.L.T., G.H., J.D.B.), London W12 0HS, United Kingdom

Address all correspondence and requests for reprints to: Dr. Gerard S. Conway, Department of Endocrinology, Middlesex Hospital, Mortimer Street, London W1T 3AA, United Kingdom. E-mail: g.conway{at}ucl.ac.uk.

Obesity, predominantly centrally distributed, is common in women with Turner syndrome (TS) and is thought to contribute to the increased risk of atherosclerosis; however, insulin concentrations are unexpectedly low. To explore this discrepancy, we assessed fat content and distribution by magnetic resonance imaging (MRI) and bioelectrical impedance (BI). Six nondiabetic, estrogen-treated women with TS were compared with six age-matched normal controls of similar body mass index. Clinical history, anthropometric measurements, biochemical markers, and MRI and BI measures of adiposity were assessed. TS women had increased intrahepatocellular lipids (IHCL) on MRI. After height adjustment, they also had an excess of total and visceral compared with sc adipose tissue (AT) than controls, without elevated insulin concentrations. BI and MRI measures correlated strongly for total and sc, but not visceral, AT in TS. IHCL was associated with cumulative estrogen-deficient years (r = 0.928; P = 0.008). Women with TS depart from the classical picture of metabolic syndrome despite an excess of total and visceral AT on MRI. Elevated IHCL in TS is associated with estrogen deficiency. BI may be useful to estimate total body fat, but does not reliably localize fat depots in TS.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
N. Wooten, V. K. Bakalov, S. Hill, and C. A. Bondy
Reduced Abdominal Adiposity and Improved Glucose Tolerance in Growth Hormone-Treated Girls with Turner Syndrome
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2109 - 2114.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
C. H. Gravholt, H. E. Poulsen, P. Ott, J. S. Christiansen, and H. Vilstrup
Quantitative liver functions in Turner syndrome with and without hormone replacement therapy
Eur. J. Endocrinol., June 1, 2007; 156(6): 679 - 686.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
C. H. Gravholt, B. E. Hjerrild, L. Mosekilde, T. K. Hansen, L. M. Rasmussen, J. Frystyk, A. Flyvbjerg, and J. S. Christiansen
Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules.
Eur. J. Endocrinol., October 1, 2006; 155(4): 583 - 592.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. A. Bondy, P. L. Van, V. K. Bakalov, and V. B. Ho
Growth Hormone Treatment and Aortic Dimensions in Turner Syndrome
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1785 - 1788.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society